Aptima® Trichomonas Vaginalis Test (ATV)

The most common curable STI

Despite being the most common curable STI, Trichomonas vaginalis (TV) is more prevalent than chlamydia (CT) and gonorrhea (NG) combined.1 3.7 Million TV cases occur annually in the U.S. Many different conditions may cause symptoms similar to TV, and co-infections can be common, making accurate diagnosis imperative for effective TV treatment.2,3
similar-symptoms-img

Up to 50% of trichomoniasis infections are missed by wet mount4

Wet mount testing sensitivity declines over time as specimens are often inadequate or lack viable, motile organisms.5

trichomoniasis-infections-img

Motile organisms decrease rapidly6

Nucleic acid amplification testing (NAAT) is recommended for the diagnosis of trichomoniasis.7

ACOG

The use of highly sensitive and specific tests, such as NAAT, are recommended over less-sensitive methods including wet-mount microscopy.8

CDC

Accurate TV detection, with or without symptoms

Our Aptima Trichomonas vaginalis assay is an FDA-cleared nucleic acid amplified test (NAAT) for trichomoniasis detection. Along with detecting trichomoniasis in both symptomatic and asymptomatic cases, it requires only a fraction of one organism to detect up to 100% of TV infections.9

Performance data by sample type9
Specimen TypeSensitivity (95% Cl)Specificity (95% Cl)
Aptima® Multitest Swab
(Vaginal Sample)
100% (94.7–100)98.2% (96.7–99.0)
Aptima® Unisex Swab
(Endocervical Sample)
100% (94.6–100)98.1% (96.7–98.9)
ThinPrep® Solution100% (95.6–100)98.6% (97.4–99.2)

Contact Us

We are here to support you. Have a question or need to talk to a Hologic team member?